Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 79.1 TWD 0.51% Market Closed
Market Cap: 9.5B TWD
Have any thoughts about
Formosa Laboratories Inc?
Write Note

Formosa Laboratories Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Formosa Laboratories Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Formosa Laboratories Inc
TWSE:4746
Tax Provision
-NT$193.2m
CAGR 3-Years
-59%
CAGR 5-Years
-45%
CAGR 10-Years
-18%
Y
YungShin Global Holding Corp
TWSE:3705
Tax Provision
-NT$352.3m
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
ScinoPharm Taiwan Ltd
TWSE:1789
Tax Provision
-NT$92.3m
CAGR 3-Years
-12%
CAGR 5-Years
1%
CAGR 10-Years
-5%
S
SCI Pharmtech Inc
TWSE:4119
Tax Provision
-NT$13.9m
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
12%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Tax Provision
-NT$1B
CAGR 3-Years
-32%
CAGR 5-Years
-52%
CAGR 10-Years
-26%
Standard Chem & Pharm Co Ltd
TWSE:1720
Tax Provision
-NT$312.3m
CAGR 3-Years
-30%
CAGR 5-Years
-21%
CAGR 10-Years
-18%
No Stocks Found

Formosa Laboratories Inc
Glance View

Market Cap
9.5B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
128.49 TWD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Formosa Laboratories Inc's Tax Provision?
Tax Provision
-193.2m TWD

Based on the financial report for Jun 30, 2024, Formosa Laboratories Inc's Tax Provision amounts to -193.2m TWD.

What is Formosa Laboratories Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-18%

Over the last year, the Tax Provision growth was -13%. The average annual Tax Provision growth rates for Formosa Laboratories Inc have been -59% over the past three years , -45% over the past five years , and -18% over the past ten years .

Back to Top